Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy is a research paper published in npj Vaccines (2025). On theSindex it has a DataRank of 0.271. It has been cited 4 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0.0295
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
National Institute of Allergy and Infectious Diseases
Grant: F30AI74785
National Institute of Allergy and Infectious Diseases
Grant: U19AI128949
National Multiple Sclerosis Society
Grant: TA-2204-39428
Novartis Pharmaceuticals Corporation
Grant: COMB157GUS20T
NIAID NIH HHS
Grant: R01 AI167372
NINDS NIH HHS
Grant: R01 NS098023
NIGMS NIH HHS
Grant: T32 GM145440
NIH HHS
Grant: S10 OD030282
NINDS NIH HHS
Grant: R01 NS124882
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5U19AI128949-04
Human anti-viral immune responses in tissues and circulation
National Institutes of Health
Grant: 5R01AI167372-04
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination
FWCI
3.71
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals